-
, flow cytometry, and computational tools, including AI, is advantageous. Our research group focuses on the development of novel non-viral gene therapies, including mitochondrial gene therapies for optic
-
life-changing treatments for glaucoma and other optic nerve diseases that cause irreversible blindness. Learn more about the Snow Vision Accelerator: https://www.snowmedical.org.au/vision-accelerator
Enter an email to receive alerts for phd-optic "https:" positions